Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sotirios Giannopoulos

Showing results (121-130 of 153) with videos related to

Pageof 16
Sort By:
European Journal of Neurology|June 16, 2025
Safety and Effectiveness of PCSK9 Inhibitors and Inclisiran in Patients With Neuromuscular Disorders and Statin IntoleranceAikaterini Theodorou, Georgia Papagiannopoulou, Alexandra Akrivaki, et al.
Journal of Clinical Medicine|February 10, 2024
Paraneoplastic Neurological Syndromes as Initial Presentation of Tumors: An Eight-Year Single-Center ExperienceKonstantinos Melanis, Maria-Ioanna Stefanou, Dimitrios K Kitsos, et al.
Journal of Neurology|March 20, 2017
Intravenous thrombolysis for ischemic stroke in the golden hour: propensity-matched analysis from the SITS-EAST registryGeorgios Tsivgoulis, Aristeidis H Katsanos, Pavla Kadlecová, et al.
Therapeutic Advances in Neurological Disorders|June 14, 2021
Acute reperfusion therapies for acute ischemic stroke patients with unknown time of symptom onset or in extended time windows: an individualized approachGeorgios Magoufis, Apostolos Safouris, Guy Raphaeli, et al.
Neurology|October 6, 2021
Cerebral Venous Sinus Thrombosis and Thrombotic Events After Vector-Based COVID-19 Vaccines: A Systematic Review and Meta-analysisLina Palaiodimou, Maria-Ioanna Stefanou, Aristeidis H Katsanos, et al.
EXCLI Journal|January 24, 2025
Current update on the neurological manifestations of long COVID: more questions than answersMaria-Ioanna Stefanou, Evangelos Panagiotopoulos, Lina Palaiodimou, et al.
Therapeutic Advances in Neurological Disorders|May 3, 2014
Dabigatran etexilate for secondary stroke prevention: the first year experience from a multicenter short-term registryGeorgios Tsivgoulis, Christos Krogias, Kara A Sands, et al.
Journal of Neurology|March 10, 2026
The predictive value of serum neurofilament light chain in achieving no evidence of disease activity-3 (NEDA-3) status in treatment-naïve patients with multiple sclerosisEvangelia Makrina Dimitriadou, Dimitrios Tzanetakos, Aikaterini Theodorou, et al.
Neurology|November 7, 2022
<i>D313Y</i> Variant in Fabry Disease: A Systematic Review and Meta-analysisLina Palaiodimou, Maria-Ioanna Stefanou, Eleni Bakola, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2023
Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysisMaria-Ioanna Stefanou, Lina Palaiodimou, Aikaterini Theodorou, et al.
Pageof 16

Showing results (121-130 of 153) with videos related to

Sort By:
Pageof 16
European Journal of Neurology|June 16, 2025
Safety and Effectiveness of PCSK9 Inhibitors and Inclisiran in Patients With Neuromuscular Disorders and Statin IntoleranceAikaterini Theodorou, Georgia Papagiannopoulou, Alexandra Akrivaki, et al.
Journal of Clinical Medicine|February 10, 2024
Paraneoplastic Neurological Syndromes as Initial Presentation of Tumors: An Eight-Year Single-Center ExperienceKonstantinos Melanis, Maria-Ioanna Stefanou, Dimitrios K Kitsos, et al.
Journal of Neurology|March 20, 2017
Intravenous thrombolysis for ischemic stroke in the golden hour: propensity-matched analysis from the SITS-EAST registryGeorgios Tsivgoulis, Aristeidis H Katsanos, Pavla Kadlecová, et al.
Therapeutic Advances in Neurological Disorders|June 14, 2021
Acute reperfusion therapies for acute ischemic stroke patients with unknown time of symptom onset or in extended time windows: an individualized approachGeorgios Magoufis, Apostolos Safouris, Guy Raphaeli, et al.
Neurology|October 6, 2021
Cerebral Venous Sinus Thrombosis and Thrombotic Events After Vector-Based COVID-19 Vaccines: A Systematic Review and Meta-analysisLina Palaiodimou, Maria-Ioanna Stefanou, Aristeidis H Katsanos, et al.
EXCLI Journal|January 24, 2025
Current update on the neurological manifestations of long COVID: more questions than answersMaria-Ioanna Stefanou, Evangelos Panagiotopoulos, Lina Palaiodimou, et al.
Therapeutic Advances in Neurological Disorders|May 3, 2014
Dabigatran etexilate for secondary stroke prevention: the first year experience from a multicenter short-term registryGeorgios Tsivgoulis, Christos Krogias, Kara A Sands, et al.
Journal of Neurology|March 10, 2026
The predictive value of serum neurofilament light chain in achieving no evidence of disease activity-3 (NEDA-3) status in treatment-naïve patients with multiple sclerosisEvangelia Makrina Dimitriadou, Dimitrios Tzanetakos, Aikaterini Theodorou, et al.
Neurology|November 7, 2022
<i>D313Y</i> Variant in Fabry Disease: A Systematic Review and Meta-analysisLina Palaiodimou, Maria-Ioanna Stefanou, Eleni Bakola, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2023
Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysisMaria-Ioanna Stefanou, Lina Palaiodimou, Aikaterini Theodorou, et al.
Pageof 16